Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-week Treatment Switched to Tazorac® Cream, 0.1% 6-week Treatment in Patients With Acne Vulgaris

NCT00469755 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT00469755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-week Treatment Switched to Tazorac® Cream, 0.1% 6-week Treatment in Patients With Acne Vulgaris
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2006
Completion date
September 30, 2006
Enrollment
302 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris